Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.8B | 2.8B | 2.9B | 2.8B |
Cost of revenue | 1.4B | 1.4B | 1.4B | 1.3B |
Gross profit | 1.4B | 1.4B | 1.5B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 483M | 477M | 478M | 465M |
Other operating expenses | 82M | 73M | 76M | 80M |
Operating income | 490M | 508M | 639M | 637M |
Non operating interest income | ||||
Income | 6M | 5M | 2M | 2M |
Expense | 580M | 591M | 598M | 596M |
Other income expense | -3M | 121M | 9M | -135M |
Pretax income | -87M | 43M | 52M | -92M |
Tax provision | 11M | 19M | 43M | 10M |
Net income | -98M | 24M | 9M | -102M |
Basic EPS | — | 0.1 | 0.0 | -0.6 |
Diluted EPS | — | 0.1 | 0.0 | -0.6 |
Basic average shares | — | 212M | 215M | 216M |
Diluted average shares | — | 213M | 215M | 216M |
EBITDA | 852M | 856M | 971M | 964M |
Net income from continuing op. | -98M | 24M | 9M | -102M |
Minority interests | -17M | -13M | -18M | -20M |
Preferred stock dividends | — | — | — | — |